Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors

Next-generation sequencing (NGS) of tumor samples and circulating tumor DNA has revolutionized diagnostic and therapeutic strategies in lung cancer. The identification of the epidermal growth factor receptor (EGFR) oncogenic driver has translated into successful therapy of advanced lung cancer using...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Thorac Dis
Päätekijät: Chen, Justin A., Riess, Jonathan W.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AME Publishing Company 2020
Aiheet:
Review Article on Mechanisms of Resistance to EGFR-targeted Therapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7330402/
https://ncbi.nlm.nih.gov/pubmed/32642199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.08.32
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia